Busch Matthew C. 4
4 · AMGEN INC · Filed May 6, 2025
Insider Transaction Report
Form 4
AMGEN INCAMGN
Busch Matthew C.
VP, Finance & CAO
Transactions
- Sale
Common Stock
2025-05-02$279.69/sh−1,000$279,690→ 4,034 total - Tax Payment
Common Stock
2025-05-02$283.78/sh−37$10,500→ 5,034 total - Tax Payment
Common Stock
2025-05-02$283.78/sh−28$7,946→ 5,071 total
Footnotes (1)
- [F1]These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.